{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Vincerx Pharma, Inc."},"Symbol":{"label":"Symbol","value":"VINC"},"Address":{"label":"Address","value":"260 SHERIDAN AVENUE,SUITE 400, PALO ALTO, California, 94306, United States"},"Phone":{"label":"Phone","value":"+1 650 800-6676"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are primarily conducted in the United States. It focuses to develop, use, manufacture, commercialize, sublicense and distribute a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation ADC platform."},"CompanyUrl":{"label":"Company Url","value":"https://www.vincerx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ahmed M. Hamdy","title":"Chairman & Chief Executive Officer"},{"name":"Amy Johnson","title":"Vice President-Medical Affairs"},{"name":"Hans-Georg Lerchen","title":"Chief Scientific Officer"},{"name":"Raquel E. Izumi","title":"President, COO, Secretary & Director"},{"name":"Tasheda Navarro","title":"Vice President-Clinical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}